Diabetes Corporation of AmericaFebruary 19, 2018

FDA 145 - Diabetes Corporation of America - February 19, 2018

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Record Details

This 145 record concerns Diabetes Corporation of America, with an inspection on February 19, 2018, covering drugs.

Company: Diabetes Corporation of America
Inspection Date: February 19, 2018
Product Type: Drugs
People: John W. Diehl (John W. Diehl, M.S.Program Division)
Thao Ta (Compliance Officer)
Mark W. Rivero (Compliance Officer)

ID · c142ac44-7180-4b14-8315-3be95730c0ba

Violation Codes1

21 CFR 20.64(d)(3)

Full citation text and observation details available on the Dashboard.